PO-457 Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers

ESMO Open - Tập 3 - Trang A409-A410 - 2018
S. Khalique1, K. Naidoo2, A.D. Attygalle3, D. Kriplani1, F. Daley1, T. Jones4, K. Fenwick5, C.J. Lord6, S. Banerjee3, R. Natrajan1
1The Institute of Cancer Research, Division of Breast Cancer, London, UK
2The Institute of Cancer Research, Division of Molecular Pathology, London, UK
3The Royal Marsden NHS Foundation Trust, Gynaecology Unit, London, UK
4The Royal Marsden NHS Foundation Trust, The Centre for Molecular Pathology, Sutton, UK
5The Institute of Cancer Research, Tumour Profiling Unit, London, UK
6The Institute of Cancer Research, The CRUK Gene Function Laboratory, London, UK